Sherwin Navaz

443 total citations
5 papers, 141 citations indexed

About

Sherwin Navaz is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Sherwin Navaz has authored 5 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Sherwin Navaz's work include COVID-19 Clinical Research Studies (2 papers), S100 Proteins and Annexins (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Sherwin Navaz is often cited by papers focused on COVID-19 Clinical Research Studies (2 papers), S100 Proteins and Annexins (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). Sherwin Navaz collaborates with scholars based in United States and China. Sherwin Navaz's co-authors include Yu Zuo, Jason S. Knight, Alyssa Harbaugh, Yogendra Kanthi, Kelsey Gockman, Jacqueline A. Madison, Srilakshmi Yalavarthi, Melanie Zuo, Claire K. Hoy and Hui Shi and has published in prestigious journals such as JAMA Network Open, Arthritis & Rheumatology and JCI Insight.

In The Last Decade

Sherwin Navaz

5 papers receiving 139 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sherwin Navaz United States	4	62	51	46	39	25	5	141
Paolo Stobbione Italy	5	129 2.1×	23 0.5×	36 0.8×	90 2.3×	35 1.4×	7	208
Kirsten Nowlan Finland	4	111 1.8×	85 1.7×	44 1.0×	47 1.2×	7 0.3×	7	197
N. A. Аrsentieva Russia	8	143 2.3×	46 0.9×	29 0.6×	83 2.1×	9 0.4×	40	215
Monica M. Schmitt United States	7	34 0.5×	53 1.0×	25 0.5×	22 0.6×	14 0.6×	19	164
Constantin Habimana Mugabo Sweden	3	95 1.5×	48 0.9×	30 0.7×	42 1.1×	13 0.5×	7	150
Carolina Artusi Italy	7	37 0.6×	46 0.9×	45 1.0×	11 0.3×	65 2.6×	11	161
Marie Koubi France	6	156 2.5×	29 0.6×	50 1.1×	88 2.3×	6 0.2×	9	220
Jubran Alqanatish Saudi Arabia	6	34 0.5×	23 0.5×	18 0.4×	27 0.7×	27 1.1×	22	179
Artemis Papadaki United Kingdom	4	69 1.1×	41 0.8×	50 1.1×	65 1.7×	11 0.4×	8	175
Renaud Cezar France	7	54 0.9×	26 0.5×	18 0.4×	21 0.5×	16 0.6×	19	139

Countries citing papers authored by Sherwin Navaz

Since Specialization

Citations

This map shows the geographic impact of Sherwin Navaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherwin Navaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherwin Navaz more than expected).

Fields of papers citing papers by Sherwin Navaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherwin Navaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherwin Navaz. The network helps show where Sherwin Navaz may publish in the future.

Co-authorship network of co-authors of Sherwin Navaz

This figure shows the co-authorship network connecting the top 25 collaborators of Sherwin Navaz. A scholar is included among the top collaborators of Sherwin Navaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherwin Navaz. Sherwin Navaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Zuo, Yu, Somanathapura K. NaveenKumar, Sherwin Navaz, et al.. (2025). Epidemiological and Translational Study of Calprotectin and Atherosclerotic Cardiovascular Disease. JAMA Cardiology. 10(7). 718–718. 1 indexed citations

2.

Zuo, Yu, Sherwin Navaz, Wenying Liang, et al.. (2023). Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events. JAMA Network Open. 6(4). e236530–e236530. 16 indexed citations

3.

Shi, Hui, Yu Zuo, Sherwin Navaz, et al.. (2022). Endothelial Cell–Activating Antibodies in COVID‐19. Arthritis & Rheumatology. 74(7). 1132–1138. 55 indexed citations

4.

Norman, Gary L., Sherwin Navaz, Yogendra Kanthi, et al.. (2022). Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19. Diagnostics. 12(6). 1324–1324. 11 indexed citations

5.

Zuo, Yu, Srilakshmi Yalavarthi, Sherwin Navaz, et al.. (2021). Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight. 6(15). 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact